NHS Scotland weight loss injections criteria: correcting the biggest misconception

The misconception: a BMI of 30 is all you need to qualify

This is the most common misunderstanding our prescribers encounter. The licensed eligibility threshold for injectable weight loss medicines (a BMI of 30 or above, or 27 or above with a weight-related condition) is set in the medicine's marketing authorisation. But NHS access is not the same thing as licensed eligibility. In Scotland, NHS provision of weight loss injections sits within a managed care framework that involves specialist weight management services, clinical prioritisation, and in most cases a requirement to have engaged with lower-intensity interventions first.

NHS Inform Scotland, which publishes health guidance for Scottish patients, outlines the general picture for diabetes and weight loss medication and is a useful starting point. The short version: meeting the licensed BMI threshold tells you a private prescriber may be able to help; it does not mean an NHS prescription is waiting for you.

A quick check worth doing right now: look up your local health board's website and search for 'tier 3 weight management'. The referral criteria and waiting times posted there will tell you more about your realistic NHS route than any national headline figure.

What Scotland's framework actually looks like in practice

Scotland does not operate the same phased commissioning rollout that NHS England is using for tirzepatide. Instead, access to injectable weight loss medicines through the NHS in Scotland is primarily managed through specialist (tier 3 and tier 4) weight management services, which typically require GP referral and involve multidisciplinary support including dietary guidance and physical activity coaching alongside any medicine.

For semaglutide (Wegovy), NICE's technology appraisal recommends it only within specialist weight management services and for a maximum of two years, Scotland follows this guidance. Ethnic background can affect the BMI threshold: for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, the reference BMI values are generally 2.5 kg/m² lower under UK guidance. Even with all criteria met, waiting lists at specialist services can be substantial. This is not a criticism of NHS Scotland; it reflects genuine demand that services are working to meet.

If you want a broader sense of how the NHS approaches these medicines across the UK, the NHS weight loss injections overview sets out the general framework clearly, and our dedicated page on weight loss injections on the NHS in Scotland goes deeper on the devolved picture.

Tirzepatide (Mounjaro) and Scotland: a different position

NICE recommended tirzepatide (Mounjaro) for NHS use in December 2024, updated in September 2025. NHS England has begun a phased rollout tied to specific BMI and comorbidity thresholds. Scotland, Wales and Northern Ireland make their own commissioning decisions, so access to tirzepatide on the NHS in Scotland is not on the same timetable. At the time of writing, Scottish health boards are at varying stages of planning for tirzepatide within NHS services.

This matters for people researching their options. If you are in Scotland and tirzepatide is clinically appropriate for you, the NHS route may not yet be available in your area. The NICE appraisal, TA1026, is the reference document for what the evidence says about tirzepatide's effectiveness and the qualifying criteria, and it is worth reading if you want to understand what 'eligible' means in clinical terms.

For adults who are eligible on licence but cannot access NHS treatment (or who prefer not to join a waiting list) a private prescription from a GPhC-registered prescriber is the lawful route. You can read about the full NHS criteria for weight loss injections to understand where the NHS and private pathways diverge.

Private prescription as a lawful alternative in Scotland

Scottish residents access private weight loss prescriptions in exactly the same way as anyone in the UK: through a regulated online pharmacy whose prescribers hold GPhC registration. The licensed eligibility criteria apply regardless of whether treatment is NHS or private, adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea, may be considered. The prescriber makes the final clinical call after reviewing your full picture.

If you're weighing up what private treatment costs alongside the NHS wait, our guide to where weight loss injections are sold privately covers what to look for in a regulated provider, including how to check any pharmacy on the GPhC register before you hand over personal information. Medicines reach you the next working day once dispatched; you can find more on our next-day delivery page if that's relevant to your situation.

A range of clinically assessed weight loss injections are available through private prescription, and if you'd like to explore treatment options, the consultation page is where to start. There's no obligation, and a named prescriber reviews every submission.